Detalhe da pesquisa
1.
Discriminating promiscuous from target-specific autoantibodies in COVID-19.
Eur J Immunol
; 53(5): e2250210, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856018
2.
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.
N Engl J Med
; 383(12): 1149-1155, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32937047
3.
Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(8): 3396-3400, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849605
4.
Daratumumab for treatment-refractory antibody-mediated diseases in neurology.
Eur J Neurol
; 29(6): 1847-1854, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098616
5.
Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE.
Int J Mol Sci
; 22(5)2021 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670902
6.
Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus.
Ann Rheum Dis
; 82(11): 1497-1499, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402488
7.
Phasor-Based Endogenous NAD(P)H Fluorescence Lifetime Imaging Unravels Specific Enzymatic Activity of Neutrophil Granulocytes Preceding NETosis.
Int J Mol Sci
; 19(4)2018 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29596303
8.
Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis.
PLoS One
; 18(3): e0282919, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920946
9.
Daratumumab for autoimmune diseases: a systematic review.
RMD Open
; 9(4)2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101819
10.
Daratumumab for the treatment of refractory ANCA-associated vasculitis.
RMD Open
; 9(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627149
11.
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells.
Mol Ther Methods Clin Dev
; 25: 311-330, 2022 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35573047
12.
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.
Sci Rep
; 11(1): 10299, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986412
13.
SARS-CoV-2 in severe COVID-19 induces a TGF-ß-dominated chronic immune response that does not target itself.
Nat Commun
; 12(1): 1961, 2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785765
14.
Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis.
J Neurol
; 267(2): 317-323, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630242
15.
Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Front Immunol
; 10: 2725, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31849944
16.
New dawn of cellular therapies in autoimmune diseases.
Mol Ther Methods Clin Dev
; 31: 101141, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027062
17.
Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab.
RMD Open
; 9(3)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37479497
18.
7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.
Ann Clin Transl Neurol
; 5(8): 900-912, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128315
19.
Analyzing Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activation in Aging and Vascular Amyloid Pathology.
Front Immunol
; 8: 844, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28824611